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Abstract: The Eurobarometer Survey of the EAPC Task Force on the Development of 
Palliative Care in Europe is part of a programme of work to produce comprehensive 
information on the provision of palliative care across Europe Aim: To identify 
barriers to the development of palliative care in Western Europe Method: A 
qualitative survey was undertaken amongst boards of national associations, eliciting 
opinions on opportunities for, and barriers to, palliative care development. By July 
2006, 44/52 (85%) European countries had responded to the survey; we report here on 
the results from 22/25 (88%) countries in Western Europe. Analysis: Data from the 
Eurobarometer survey were analysed thematically by geographical region and by the 
degree of development of palliative care in each country. Results: From the data 
contained within the Eurobarometer, we identified six significant barriers to the 
development of palliative care in Western Europe: (i) Lack of palliative care 
education and training programmes (ii) Lack of awareness and recognition of 
palliative care (iii) Limited availability of/knowledge about opioid analgesics (iv) 
Limited funding (v) Lack of coordination amongst services (vi) Uneven palliative 
care coverage. Conclusion: Findings from the EAPC Eurobarometer survey suggest 
that barriers to the development of palliative care in Western Europe may differ 
substantially from each other in both their scope and context and that some may be 
considered to be of greater significance than others. A number of common barriers to 
the development of the discipline do exist and much work still remains to be done in 
the identified areas. This paper provides a road map of which barriers need to be 
addressed. 
 









The European Association for Palliative Care (EAPC) Task Force on the 
Development of Palliative Care in Europe was founded in 2003 under the leadership 
of Dr. Carlos Centeno from the University of Navarra. The Task Force combines the 
expertise of the EAPC with that of the International Observatory on End of Life Care 
(IOELC), Hospice Information (itself a partnership between Help the Hospices and St 
Christopher’s Hospice, UK) and the International Association for Hospice and 
Palliative Care (IAHPC).1 A progress report on the work of the Task Force was 
published in 2004,2 initial findings were first presented in 2006,3 the EAPC Atlas of 
Palliative Care in Europe was published in 2007,4 and the EAPC Review of Palliative 
Care in Europe appeared in 2008.5 Associated articles have been subsequently 
published in peer-reviewed journals.6 7 8 The work of the Task Force has also been 
utilised to compile a technical report for the European Parliament,9 and a set of 
specific EAPC country reports are disseminated via the web pages of the EAPC, as 
well as via links from the web pages of other organisations participating in the Task 
Force.  
 
The aim of the Task Force is to undertake a reliable and comprehensive analysis of 
palliative care developments within each European country, in order to generate and 
disseminate an ‘evidence base’ of clear and accessible research-based information 
concerning the current provision of the discipline across both countries and regions. It 
is hoped that this overview of palliative care provision, achievements and challenges 
will provide governments and policymakers with a new and improved understanding 
of the development of programmes to promote palliative care within the European 
region and that this will, in turn, assist the providers of palliative care services in a 
direct, practical way through the development of future policy and practice. The 
specific aim of this particular study is to identify barriers to the development of 




From the outset, the Task Force sought to work collaboratively in a manner that 
would bring together experience from groups and institutions working to promote 
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palliative care in their own countries. The national palliative care association of each 
country was therefore requested to nominate someone with extensive local knowledge 
to participate in the project (for example, a chairperson or secretary). The EAPC Head 
Office, the IAHPC, Help the Hospices and the IOELC provided vital information in 
identifying national associations, local contacts, and key palliative care workers in 
each country and region who had studied the development of hospice and palliative 
care in their own setting and who could provide specific data to assist policy makers 
and planners; these organisations also provided valuable assistance in the compilation 
of the qualitative ‘Eurobarometer’ survey that was disseminated amongst the boards 
of national associations, eliciting opinions and views on opportunities for, and barriers 
to, palliative care development.  
 
The Eurobarometer Survey was developed to gain insights into the views of key 
palliative care leaders across the 52 countries of the WHO European region in relation 
to the current state of palliative care in each country. This qualitative survey included 
questions on the strengths and weaknesses of palliative care at the country level, and 
aimed to show the achievements and breakthroughs that had been made in each 
jurisdiction. The survey had five main sections: 
 
o Background questions (name, contact details, palliative care organisation, 
etc.); 
o Questions on the current state of development of palliative care in each 
country (has improved; remained the same; got worse, etc.); 
o Questions on barriers to, and opportunities for, the development of palliative 
care in each country (for example, availability of opioids; other issues relevant 
to the development of palliative care); 
o Questions on policy (for example, national health policies; euthanasia and 
assisted suicide; Recommendations on Palliative Care from the Council of 
Europe (2003)10); 
o Questions on the future of palliative care in each country. 
 
A caveat was included within the survey to ensure that the participant was aware that 
the responses they provided would be assumed to reflect the vision of the palliative 
care organization that they represented; participants were therefore encouraged to 
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discuss details of the survey and their responses to it with colleagues prior to 
submission in order to provide as balanced a view as possible. 
 
The resulting data were analysed thematically by geographical region and by the 
degree of development of palliative care. A thematic mode of analysis allows the 
participant to be centre stage, and as such was considered a suitable choice for this 
particular study.11 Common themes were revealed in the survey through qualitative 
secondary analysis, data synthesis and ‘meta analysis’ of data findings. Initially, the 
survey responses were carefully reviewed in order to identify relevant concepts; these 
concepts were then sorted into potential themes, data relevant to each theme collated, 
and theoretical categories developed. Themes were modified and developed as survey 
data were revisited and analysis progressed. The aim of categorizing in this manner 
was to satisfy the theoretical requirement of qualitative research through the 
development of theoretical categories arising directly from evidence expressing 
personal meaning.12 The overall aim of the categorizing process was to give meaning 
to the voices of respondents within the survey and to represent them as accurately as 
possible.13  
 
In this paper, we focus on findings concerned with one part of the Eurobarometer 
Survey, relating specifically to 22/25 (88%) countries in Western Europe. Each 
country makes a contribution to this paper, although in some cases selected parts of 
text have been edited to improve the English language fluency. A list of Western 
European countries that did and did not respond to the Eurobarometer Survey are 
shown in Table 1. 
 








































Western Europe is a region generally thought to contain countries with well-
developed palliative care networks,14 yet significant barriers to the development of 
the discipline do exist. Whilst it is acknowledged that the barriers described within 
this paper may differ substantially from each other in both their scope and context and 
some may be considered to be of greater significance than others, a number of 
common barriers to the development of the discipline in Western Europe do exist: (i) 
Lack of palliative care education and training programmes (ii) Lack of awareness and 
recognition of palliative care (iii) Limited availability of/knowledge about opioid 
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analgesics (iv) Limited funding (v) Lack of coordination amongst services (vi) 
Uneven palliative care coverage. 
 
(i) Lack of palliative care education and training programmes 
 
Lack of palliative care education and training opportunities is the most frequently 
reported barrier to the development of palliative care in Western Europe (39 
references by 19 different countries). In Finland, Austria, Belgium, Greece, France, 
Italy, Norway, Luxembourg, and Turkey, it is reported that an insufficient focus on 
palliative care within both undergraduate and postgraduate medical education results 
in a lack of University curricula and training programmes for health care professionals 
and medical students. A similar situation exists in Malta, where it is reported that the 
lack of formal education for undergraduates combined with a lack of clearly defined 
career progression for doctors often results in medical graduates choosing not to enter 
palliative care. In Germany, it is reported that palliative care is not integrated into the 
obligatory syllabus for medical or nursing students, and that the majority of medical 
universities do not have their own university palliative care unit and are not obligated 
to organise tuition in the field of palliative medicine.  
 
Against this backdrop, shortages of a skilled palliative care workforce resulting from 
a lack of education and training are reported to be affecting the delivery of palliative 
care; for example, in Norway the lack of palliative care personnel is acknowledged, 
and in Ireland there is a shortage of certain grades of staff with specialist palliative 
care training. This is also the case in the United Kingdom, where difficulties are 
reported in the recruitment of doctors, nurses and allied health care professionals: 
 
‘The UK is currently facing shortages of healthcare staff and this is affecting 
palliative care amongst other specialisms. Even when funding has been made 
available to support palliative care, services are not always able to grow as 
quickly as they would like because of the time and resources required to train 
new specialists. There is also a need for more training for generalist healthcare 
staff in palliative care’ (United Kingdom) 
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Lack of palliative care education and training programmes is reported as resulting in a 
dearth of research at the national level within Israel and also Iceland, where only a 
very limited number of journal articles have been published on palliative care and 
pain control. In Germany, research activities in the field of palliative medicine and 
palliative care are increasing, but still remain at an insufficient level with improved 
networking and increased funding and education in research required. 
 
(ii) Lack of awareness and recognition of palliative care  
 
Across the Western European region, respondents report a lack of awareness and 
recognition about issues of palliative care (19 references by 14 different countries). In 
Turkey and Greece, people are not very well informed about the discipline, with a 
similar situation existing in Denmark, where many people, including politicians still 
think it is about ‘loving tender care’ as opposed to highly qualified professional care. 
Even in countries where the public has developed an awareness of the discipline of 
palliative care, problems of perception remain: 
 
‘Even though there are information programmes of hospices and palliative 
care/medicine representatives, public awareness of palliative care services is 
not as good as it should (be)…According to a poll in 2004, only 3% of the 
public know what the term palliative care means’ (Germany) 
 
A degree of passivity on the part of medical professionals in many areas continues to 
be a potential barrier to the development of palliative care, and, as we have reported 
elsewhere,7 the discipline lacks recognition in several Western European countries. 
Although there is limited palliative care accreditation provided by Universities and 
other academic organisations, policy makers and government departments fail to 
recognise the discipline as a medical or nursing specialty in Austria, Cyprus, Greece, 
and Netherlands. In Israel, although discussions on the certification of palliative 
medicine as a sub-specialty are progressing,15 it has yet to be fully embraced into the 
traditional health care system. A similar situation is reported from Denmark, Iceland 
and Sweden, although there is some evidence that a process of palliative care 
certification is being developed in these particular countries. In Finland, it is reported 
that despite similar progress in relation to the certification of palliative medicine, 
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Ministry of Health recognition of the discipline remains essential to clarify the 
process of definition:7 
 
‘Palliative medicine should have a (sub)speciality to be able to state what it is. 
One can not organise something which does not exist. So far anyone or any 
unit can call themselves a palliative care unit or specialist if there is no official 
recommendations and requirement. In general opinion, so far, all health care 
professionals can give palliative care – no need for specialised knowledge and 
organisation is needed. Therefore we need the speciality to be able to organise 
education and a specialised palliative care service’ (Finland) 
 
Whilst there is information to show that there are some palliative care postgraduate 
courses and University diplomas in Italy,7 the difficulty in providing services to a 
homogenous standard without adequate professional certification for physicians and 
nurses remains a potential barrier to the development of the discipline; it is suggested 
that this virtual absence of professional certification fails to guarantee patients high 
quality palliative care services. In Portugal, it is reported that there is little political 
will to implement palliative care, whilst in Spain a lack of political commitment to 
palliative care from some regional health ministries is described. The medical model 
was perceived as dominant according to most respondents in the survey, and was 
often seen to take priority over care for the dying patient; for example, in Turkey, a 
predominant focus on curative treatment is reported, whilst in France, the biomedical 
model is pre-eminent in medicine and in the plan against cancer. A similar story 
emerges from the United Kingdom: 
 
‘The main barrier to the development of palliative care is also the reason it 
developed as a distinct specialism in the first place. It is the tendency of 
mainstream health services to focus on curing disease and saving lives and for 
this to mean that care of the dying is not given priority. Because improvements 
in quality of life are difficult to measure, palliative care has tended not to 
feature in national NHS targets…The tendency to focus on curing disease has 
also meant that many healthcare professionals perceive death to be a poor 
outcome and may not be comfortable discussing palliative care with patients 
because it is associated with dying’ (United Kingdom) 
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 (iii) Limited availability of/knowledge about opioid analgesics 
 
A frequently reported barrier to the development of palliative care in Western Europe 
is the limited availability of/knowledge about opioid analgesics (14 references by 
eight different countries). In Greece, Portugal, and Turkey, the lack of availability and 
choice of opioids is identified as a problem; the situation is similar in Malta where 
diamorphine is available in state hospitals but not in privately owned pharmacies 
because of the fear of theft. In Portugal, the prohibitive cost and the lack of available 
funding streams for the purchase of expensive opioids is perceived to be a significant 
barrier, whilst restricted availability of certain opioids in Greece is often related to 
issues of cost-effectiveness: 
 
‘The pharmaceutical companies are not interested in distributing different 
kinds of opioids (newer agents) because [the markets] are not [profitable] for 
them’ (Greece) 
 
Both the United Kingdom and Ireland report a lack of availability of a range of 
opioids outside of standard working hours, whilst problems relating to legislation and 
government ‘bureaucracy’ concerning opioids come from Cyprus and Greece. A 
similar situation exists in Austria, where prescribing strong opioids requires the 
completion of a number of different forms and the provision of rigorous safeguards in 
relation to storage and distribution. 
 
Lack of professional knowledge about the prescription of strong opioids amongst 
physicians and other health professionals is reported to be a problem in Austria, 
Cyprus, Finland, France, Germany, Israel, Italy, Netherlands, Norway, and Spain. In 
Luxembourg, despite optimal national availability of strong opioids, there is a lack of 
knowledge about their prescription and use amongst both doctors and nurses. The lack 
of knowledge relating to the prescription of opioids results in prejudices and an 
‘opioid mentality’ among healthcare professionals in a number of countries (for 
example, Austria, Luxembourg, and Switzerland); this often results in reluctance and 
fear on the part of doctors to prescribe the necessary doses of opioids to patients, such 
as in Turkey, and also in the United Kingdom, where the high-profile conviction of Dr 
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Harold Shipman, a GP who had murdered over 215 of his patients, may have made 
GPs more reluctant to prescribe diamorphine for their patients. 
 
Respondents from nine countries (Austria, Belgium, France, Luxembourg, 
Netherlands, Norway, Switzerland, Turkey, United Kingdom) suggest the lack of 
knowledge about the use of opioids may result in irrational myths and negative 
stereotypes about the dangers of abuse; the close association between the use of 
opioids in palliative care and the psychological or physical problems of drug 
addiction/dependence has been prevalent for many years amongst members of the 
general public in these countries. The stigmatizing and taboo status of opioid use is 
reported as a barrier to the development of palliative care in Belgium, where there is a 
long-standing perception that the use of morphine inevitably leads to the death of the 
patient: 
 
‘…a mental barrier is the taboo on morphine (as many times emphasised by 
Twycross); this is a vicious circle: “morphine is a killer” so we start too late 
due to the resistance of the patient, the family or the doctor; then the patient 
dies soon after first admission because death was so near and subsequently the 
reaction often is: “I told you the morphine would kill him”’ (Belgium) 
 
(iv) Limited  funding 
 
A lack of sufficient funding for the provision of palliative care is perceived as a 
barrier to the development of the discipline in Western Europe (11 references by ten 
different countries). For example, lack of state funding is described as a barrier in 
Belgium, where there is insufficient financial support by the government for local and 
national initiatives and hardly any money for research in the field of palliative care. In 
Ireland, Israel, Netherlands, Switzerland, and Turkey, there is a reported lack of 
sufficient public funding for the provision of palliative care, with a similar situation in 
Germany where there exists a need to find funding from private and charitable 
sources to pay for establishing and maintaining palliative care services. Some 
respondents highlighted funding difficulties due to political bureaucracy; for example, 
in Austria where the necessary political motivation to spend more money on hospice 
and palliative care services is reported as being a very slow process. Insufficient 
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funding of palliative care services concomitant with a lack of clarity and transparency 
in the way in which funding is made available is reported from the United Kingdom: 
 
‘Palliative care in the UK was pioneered by local hospice charities and was 
originally funded entirely from voluntary income. Over time, palliative care 
services have developed in both the NHS and the voluntary sector and the 
NHS has increased the contribution it makes to palliative care services. 
However, services in both sectors still receive a significant proportion of 
income from charitable sources. The NHS contribution is variable around the 
country, and tends to be a contribution towards costs rather than payment for a 
specific level of services…more resources will be needed to really mainstream 
palliative care practice across generalist healthcare’ (United Kingdom) 
 
A number of respondents report that limited funding often results in education and 
training initiatives being abandoned; this may, in turn, result in a deterioration of 
service provision. In Greece, slow development and expansion of palliative care 
services in primary, secondary and tertiary health care due to limited funding is 
perceived to be a barrier to the development of the discipline; a similar story emerges 
from Belgium: 
 
‘We try to develop guidelines, standards for (nurse) education and a national 
registration system. Due to lack of means most of this is executed by a few 
enthusiastic people in their spare time. The danger is that lack of means leads 
to the development of systems that are not sufficiently professional based’ 
(Belgium) 
 
(v) Lack of coordination amongst services  
 
The lack of effective coordination amongst different bodies responsible for the 
delivery of palliative care services is often reported as a barrier to the development of 
the discipline in Western Europe (11 references by nine different countries). For 
example, in Austria there a number of different authorities responsible for 
implementation of the required services (federal and regional authorities, social health 
insurance and retirement pension insurance companies). In Ireland, the lack of 
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coordination amongst palliative care providers may make it difficult to deliver an 
integrated health care service and homogeneous standards of palliative care in the 
future. The lack of a coordinated referral system to access palliative care services is a 
potential barrier to the development of the discipline in Malta, where reluctance on 
the part of doctors to refer patients to palliative care services is deemed to have an 
adverse affect on patient care. Lack of coordination between state and voluntary 
services is reported in Greece, Finland, and Italy: 
 
‘The devolution of many political decisions concerning health care from the 
central government to the regional government had made it difficult to 
propose homogeneous standards for the provision of palliative care with the 
development of very different reimbursement and accreditation models all 
over the country…In some cases this leads to different attitudes of non-profit 
organizations which have been developing models of care providers in 
competition with and in substitution to hospital-based and NHS professionally 
driven models’ (Italy) 
  
There is a lack of a national coordination board in Luxembourg, whilst in Portugal it 
is reported that although there is a pain network and a palliative care network written 
into public documents, these are not adequately implemented in the field. Inadequate 
national standards to regulate and determine the quality of palliative care provision 
are also reported as a barrier to the development of the discipline in the Netherlands.  
 
Lack of coordination between different medical specialties and disciplines is a barrier 
to the development of palliative care in a number of countries; for example, in Italy: 
 
‘[There is] strong debate among oncology, anaesthesia and other medical 
specialties to keep control of palliative care services…At the moment 
depending on regional differences palliative care services are directed by 
oncologists or by anaesthesiologists…[there is] continuous debate with GPs 
about their role in palliative care in integration with specialist services…There 
is a danger of bureaucratization…in a way that the revolutionary role of 
palliative care within modern medicine is lost or is confined in few 
“excellence” centres’ (Italy) 
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 (vi) Uneven palliative care coverage  
 
Uneven palliative care coverage is the least reported barrier to the development of 
palliative care in Western Europe (seven references by seven different countries). In 
Germany there are a considerable number of palliative care services, though not 
enough to cover the needs of the population; the distribution of services is also 
uneven, and in some areas there exists a substantial number of ‘blind spots’. The 
inability to provide comprehensive coverage is also reported from Greece, where it is 
stated that at a national level, much still needs to be done to achieve the required 
coverage. Similar problems in relation to the distribution of palliative care are being 
experienced in Finland, and also in Switzerland, where many cantons do not have any 
palliative care services. In Turkey, it is reported that a wider range of palliative care 
programmes is of paramount importance, whilst in Denmark, palliative care appears 
to be occurring spasmodically across the country, rather than according to any 
specific strategy; this often results in counties with little coverage:  
 
‘…the development (of palliative care) has been very unevenly spread in the 
country, in some counties there is still no specialist palliative care service, in 
some the so-called specialist palliative care service is very far from WHO and 
international standards…It is a good thing to have hospices, but the 
government seems to believe that the palliative care needs are covered by 12 
hospice beds in each county’ (Denmark) 
 
One of the reasons why there is uneven coverage in a number of countries in Western 
Europe is an absence of sufficient public funding. In the United Kingdom, this factor 
is reported to affect the ability to provide comprehensive palliative care coverage: 
 
‘The level of investment through personal giving has enabled palliative care 
services to develop more rapidly than they would have done if they had been 
entirely reliant on public funding. The disadvantage has been that these 
developments have been located where there was a public will and the means 
to do so, rather than following any strategic plan. This may leave some areas 




Data collected in the Eurobarometer survey reveal a number of barriers to the 
development of palliative care in the countries of Western Europe (Table 2). 
 
Table 2: Most frequently reported barriers to the development of palliative care 
in Western Europe 
 
Most frequently reported barrier to 
the development of palliative care 
Number of references by number of 
different countries 
Lack of palliative care education and 
training programmes 
39 references by 19 different countries 
Lack of awareness and recognition about 
palliative care 
19 references by 14 different countries 
Limited availability of/knowledge about 
opioid analgesics 
14 references by eight different 
countries 
Limited funding 11 references by ten different countries 
Lack of coordination amongst services 11 references by nine different 
countries 
Uneven palliative care coverage. Seven references by seven different 
countries 
 
The barriers identified differ considerably in scope and context, and of course some 
are more significant than others. For example, in countries where palliative care is not 
integrated into undergraduate and postgraduate education and training programmes 
for medical students and other health professionals, lack of awareness and recognition 
of the discipline may continue unabated, and the discipline is thereby rendered 
‘invisible’ amongst other medical specialties. This lack of education and training 
programmes, combined with the absence of clearly defined career progression for 
doctors within palliative care, often results in medical graduates choosing not to enter 
the discipline. In turn, an inability to deliver homogeneous standards of palliative care 
in a country due to the lack of suitably qualified staff may result. A lack of palliative 
care education and training programmes may also result in limited knowledge about 
opioid analgesics amongst health professionals (for example, in the prescription of 
opioids for pain control) and in a dearth of research at the national level.  
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Similarly, limited funding impacts upon the provision of palliative care in a variety of 
ways; for example where a lack of coordination between services leads to different 
reimbursement and accreditation models being developed. Inadequate funding often 
results in palliative care services occurring spasmodically across the country, rather 
than according to any specific strategy or plan, and this may leave some areas 
underprovided for compared with others. Limited funding also circumscribes the 
availability of opioid analgesics in some countries, and may lead to the development 
of education and training systems that are not sufficiently professional-based or that 
are abandoned completely.  
 
There are a number of instances where barriers may intertwine and interconnect with 
each other. For example, a lack of palliative care education and training concomitant 
with a lack of knowledge about the use of opioids may result in the promulgation of 
irrational myths and negative stereotypes about the dangers of opioid abuse amongst 
health professionals. A lack of awareness and recognition of palliative care can result 
in uneven coverage in countries where services that are promoted as ‘specialist 
palliative care services’ are far removed from established international standards, or 
where governments consider that the palliative care needs of the population are 
covered by a small number of hospice beds in each area. Within this context, the 
restricted focus on resources allocated solely for hospices may be a potential barrier to 
the provision of palliative care for the wider population; for example, in some 
Western European countries, palliative care is still rarely integrated into hospital 
departments or nursing and care homes. Lack of government awareness and 
recognition of palliative care often means that the political will necessary to generate 
funding is absent or that palliative care does not feature in government financial 
targets. 
 
Findings from the EAPC Eurobarometer survey suggest that barriers to the 
development of palliative care in Western Europe may differ substantially from each 
other in both their scope and context and that some may be considered to be of greater 
significance than others. A number of common barriers to the development of the 
discipline do exist and much work still remains to be done in the identified areas. This 
paper provides a road map of which barriers need to be addressed. 
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The following countries in Western Europe were invited to participate in the 
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